# Multiple Electrode Aggregometry & Clopidogrel Resistance

> **NCT01991093** · — · COMPLETED · sponsor: **Elpen Pharmaceutical Co. Inc.** · enrollment: 280 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM)
- Coronary Artery Disease (CAD)
- Myocardial Infraction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01991093
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2021-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01991093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01991093, "Multiple Electrode Aggregometry & Clopidogrel Resistance". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01991093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*